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Consistent Timed Therapy - q 8 hours
	 •		3:00	pm;	11:00	pm;	7:00	am


















Key Factors for Success




















IL-2 Assessment Criteria 
 
System Relative Criteria Yes No Absolute Criteria Yes No 
Cardiac ST 120-130   ST.>130*   
    EKG Ischemia   
    Atrial Fibrillation   
 Frequent PVCs   Bigeminy, V.Tach.   
    Elevated CPK-MB   
Dermatologic.    Moist Desquamation   
GI Diarrhea 
>1000cc/shift 
  Refractory vomiting   
 Abdominal 
distention 
  Severe abdominal distention 
affecting breathing 
  
    Unrelenting abdominal pain   
Hemodynamic    Pressors needed for blood 
pressure 
  
 Guiac +Stools, 
sputum or emesis 
  Frank blood in stools, sputum   
 Platelets. <50,000   Platelets<30,000   
Immune    Strong clinical suspicion or 
documented 
  
Neurologic    Mental status changes   
    Disorientation, Vivid dreams or 
emotional lability 
  
Pulmonary Resting SOB   >4L for sat >95%   
 Crackles 1/3 up 
chest 
  Crackles ½ up chest   
 3-4 L for sat> 95%   40% O2 mask for sat >95%   
    Intubation   
Renal Urine output           
<160ml/8 hrs 
  Urine <80ml/8hr   
 Creatinine 2.5 – 2.9   Creatinine at or > than 3   
Weight Gain 15 % over baseline      
 
Hold dose if any relative criteria are checked.  Take corrective action and reassess next scheduled time. 
D/C therapy 3 or > relative criteria are checked, 1 absolute criteria or dose held x3. 
 
POSSIBLE SIDE EFFECTS: 
 Allergic reactions are rare but signs of reactions are shortness of breath, wheezing, rash, itching, 
lightheadedness or palpitations. 
 Flu like symptoms: fever, headache, chills, muscle and joint aches, along with fatigue. 
 Decrease in the number of white blood cells, red blood cells and platelets.  This will increase your risk 
of fatigue, infection and bleeding. 
 Soreness in the mouth and throat. 
 Moderate to severe nausea and vomiting. 
 Diarrhea 
 Rash on your legs, arms, back or chest. 
 Itching – dry skin 
 Decreased appetite 
 Rectal Bleeding 
 Effects on the heart 
 Chest pain 
 Rapid irregular beat 
 Heart attack – this is rare 
 Urine that is dark or foul smelling 
 Irritability, restlessness or agitation 
 Hallucinations 
 Confusion 
 Trouble sleeping or nightmares 
 Difficulty concentrating 
 Fluid build up in your lungs with difficulty Catching your breath 
 Weight gain – this is temporary 
 Swelling of the hands and the face 
 Low blood pressure 
 Changes in your liver enzymes 
 
WHAT YOU CAN DO: 
 Do your mouth care after each meal and before going to bed. 
 Avoid mouth washes with alcohol in them 
 Stand up slowly and catch your balance before changing position 
 Let us know if you are feeling confused, having nightmares or having difficulty with mood shifts 
 Keep your skin moist – use non- steroid lotion may times a day 
 Let us know if you are having diarrhea, constipation or blood in your stools 
 Take no medications over or under the counter without letting us know 
 Stay in bed only to sleep – keep mobile 
Lehigh Valley Hospital 
John and Dorothy Morgan Cancer Center 
ALDESLEUKIN - HIGH DOSE IL-2 
1 Course
Cycle #1 – IL-2 Q 8 hours
X maximum 14 doses
Cycle #2 – IL-2 Q 8 hoursRest 7-10 days Rest 8-12 weeks
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